News

April 20, 2018
An adjuvant therapy for high-risk sage III melanoma resulted in significantly longer recurrence-free survival than placebo, with no new toxic effects identified. ... Read More
April 20, 2018
A significant percentage of patients with inoperable, advanced, or metastatic ALK-positive inflammatory myofibroblastic tumors were confirmed to have partial or complete tumor shrinkage after treatment with an ALK-targeted anti-cancer therapy. ... Read More
April 20, 2018
A summary of studies presented at the 2018 American Association for Cancer Research Annual Meeting. ... Read More
April 20, 2018
The US Food and Drug Administration approved the intravenous formulation of a drug as an alternative therapy option for patients experiencing chemotherapy-induced nausea and vomiting. ... Read More
April 20, 2018
An off-the-shelf, T-cell receptor-less CD19 CAR T-cell product showed positive results in preclinical specificity, functionality, and efficacy studies. ... Read More
April 19, 2018
Upfront stereotactic radiosurgery is associated with improved survival in patients with brain metastases from small-cell lung cancer, compared with whole-brain radiation therapy. ... Read More
April 19, 2018
Jeremy S Abramson, MD, MMSc, and John P Leonard, MD, debated whether CAR T-cell therapies will have a major impact on outcomes for patients with recurrent DLBCL over the next 3 years. ... Read More
April 19, 2018
In highly selected patients with locally advanced pancreatic cancer, surgical resection after neoadjuvant therapy is feasible and associated with longer overall survival, researchers report. ... Read More
April 19, 2018
U.S. regulators have expanded use of AstraZeneca's lung cancer drug Tagrisso to include initial treatment of patients with a specific genetic mutation ... Read More
April 18, 2018
The US Food and Drug Administration approved a drug for the second-line treatment of thrombocytopenia. ... Read More